Alicja Hubalewska-Dydejczyk

Author PubWeight™ 42.84‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Technetium-99m-sestamibi subtraction scintigraphy vs. ultrasonography combined with a rapid parathyroid hormone assay in parathyroid aspirates in preoperative localization of parathyroid adenomas and in directing surgical approach. Clin Endocrinol (Oxf) 2006 2.30
2 Clinical results of radionuclide therapy of neuroendocrine tumours with 90Y-DOTATATE and tandem 90Y/177Lu-DOTATATE: which is a better therapy option? Eur J Nucl Med Mol Imaging 2011 2.08
3 Gastroenteropancreatic neuroendocrine neoplasms: a 10-year experience of a single center. Pol Arch Med Wewn 2015 1.57
4 Factors connected with the female sex seem to play an important role in differentiated thyroid cancer. Gynecol Endocrinol 2011 1.41
5 Comment on Pepe et al.: somatostatin receptor SPECT. Eur J Nucl Med Mol Imaging 2012 1.39
6 Evaluation of Halle, Miami, Rome, and Vienna intraoperative iPTH assay criteria in guiding minimally invasive parathyroidectomy. Langenbecks Arch Surg 2009 1.21
7 Intraoperative parathyroid hormone assay improves outcomes of minimally invasive parathyroidectomy mainly in patients with a presumed solitary parathyroid adenoma and missing concordance of preoperative imaging. Clin Endocrinol (Oxf) 2007 1.11
8 Five-year follow-up of a randomized clinical trial of total thyroidectomy versus Dunhill operation versus bilateral subtotal thyroidectomy for multinodular nontoxic goiter. World J Surg 2010 1.10
9 Glucagon-like peptide-1 receptor imaging with [Lys40(Ahx-HYNIC- 99mTc/EDDA)NH2]-exendin-4 for the detection of insulinoma. Eur J Nucl Med Mol Imaging 2012 1.10
10 Treatment and screening of hypothyroidism in pregnancy: results of a European survey. Eur J Endocrinol 2011 1.00
11 Clinical value of intraoperative neuromonitoring of the recurrent laryngeal nerves in improving outcomes of surgery for well-differentiated thyroid cancer. Pol Przegl Chir 2011 0.98
12 Reference values for thyroid volume established by ultrasound in Polish schoolchildren. Endokrynol Pol 2012 0.94
13 Iodine-deficiency prophylaxis and the restriction of salt consumption - a 21st century challenge. Endokrynol Pol 2010 0.92
14 The prevalence of benign and malignant neoplasms in acromegalic patients. Endokrynol Pol 2010 0.91
15 Efficacy and complications of neurosurgical treatment of acromegaly. Pituitary 2011 0.90
16 [A case of Graves-Basedow disease with orbitopathy and papillary thyroid cancer]. Endokrynol Pol 2009 0.86
17 Iodine prophylaxis--the protective factor against stomach cancer in iodine deficient areas. Eur J Nutr 2007 0.85
18 An assessment of the effectiveness of iodine prophylaxis in pregnant women - analysis in one of reference gynaecological-obstetric centres in Poland. Endokrynol Pol 2015 0.84
19 Diagnostics and Treatment of Thyroid Carcinoma. Endokrynol Pol 2016 0.82
20 Adenomatoid tumour of the adrenal gland: a case report and literature review. Pol J Pathol 2010 0.82
21 Peptide receptor radionuclide therapy as a potential tool for neoadjuvant therapy in patients with inoperable neuroendocrine tumours (NETs). Eur J Nucl Med Mol Imaging 2011 0.82
22 Factors connected with the female sex seem to play an important role in differentiated thyroid cancer. Gynecol Endocrinol 2011 0.81
23 Evaluation of gastric emptying in familial and sporadic Parkinson disease. Parkinsonism Relat Disord 2009 0.80
24 Gastroduodenal neuroendocrine neoplasms including gastrinoma - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol 2013 0.80
25 [Withdrawal syndrome complicated with heart left ventricle dysfunction in young woman addicted to alcohol]. Przegl Lek 2007 0.80
26 Five-year follow-up of a randomized clinical trial of unilateral thyroid lobectomy with or without postoperative levothyroxine treatment. World J Surg 2010 0.79
27 The predictive value of the IGF-1 level in acromegaly patients treated by surgery and a somatostatin analogue. Endokrynol Pol 2011 0.78
28 Recommendations of the Polish Society of Endocrinology and Polish Diabetes Association for the management of thyroid dysfunction in type 1 and type 2 diabetes. Endokrynol Pol 2013 0.78
29 Imaging of inflamed carotid artery atherosclerotic plaques with the use of 99mTc-HYNIC-IL-2 scintigraphy in end-stage renal disease patients. Eur J Nucl Med Mol Imaging 2012 0.78
30 [The incidence of neoplasm in women using contraceptives]. Przegl Lek 2010 0.77
31 Can treatment using radiolabelled somatostatin analogue increase the survival rate in patients with non-functioning neuroendocrine pancreatic tumours? Nucl Med Rev Cent East Eur 2011 0.77
32 Acromegaly--a novel view of the patient. Polish proposals for diagnostic and therapeutic procedures in the light of recent reports. Endokrynol Pol 2014 0.77
33 Amiodarone and the thyroid. Endokrynol Pol 2015 0.77
34 Adrenal incidentaloma in adults - management recommendations by the Polish Society of Endocrinology. Endokrynol Pol 2016 0.77
35 Thyroid disorders-assessments of trace elements, clinical, and laboratory parameters. Biol Trace Elem Res 2010 0.77
36 Positive family history of thyroid disease as a risk factor for differentiated thyroid carcinoma. Pol Arch Med Wewn 2011 0.77
37 Dietary patterns as risk factors of differentiated thyroid carcinoma. Postepy Hig Med Dosw (Online) 2012 0.77
38 Efficacy and safety of 90Y-DOTATATE therapy in neuroendocrine tumours. Endokrynol Pol 2011 0.77
39 Nephrotoxicity after PRRT - still a serious clinical problem? Renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATATE and 90Y/177Lu-DOTATATE. Endokrynol Pol 2013 0.76
40 Utility of intraoperative bilateral internal jugular venous sampling with rapid parathyroid hormone testing in guiding patients with a negative sestamibi scan for minimally invasive parathyroidectomy--a randomized controlled trial. Langenbecks Arch Surg 2009 0.76
41 Polish Society of Endocrinology Position statement on endocrine disrupting chemicals (EDCs). Endokrynol Pol 2015 0.76
42 Are RECIST criteria sufficient to assess response to therapy in neuroendocrine tumors? Clin Imaging 2012 0.76
43 [Management of Graves' orbitopathy. Comments on the EUGOGO consensus statement]. Endokrynol Pol 2009 0.76
44 [Assessment of 25(OH)D3, concentration levels in patients with papillary thyroid cancer compared to patients with Hashimoto's thyroiditis]. Przegl Lek 2013 0.76
45 Polish experience in Peptide receptor radionuclide therapy. Recent Results Cancer Res 2013 0.75
46 Comment on long-term risk in radioiodine treatment of hyperthyroidism. Eur J Nucl Med Mol Imaging 2008 0.75
47 Expression of cyclooxygenase-2 (COX-2) in pituitary tumours. Med Sci Monit 2012 0.75
48 PRRT as neoadjuvant treatment in NET. Recent Results Cancer Res 2013 0.75
49 Neuroendocrine neoplasms of the small intestine and appendix - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol 2017 0.75
50 Does combination of "cold" and "hot" somatostatin analogs prolong survival of patients with neuroendocrine neoplasms? Endocr J 2016 0.75
51 Gastroduodenal neuroendocrine neoplasms, including gastrinoma - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol 2017 0.75
52 Epidemiology of gastroenteropancreatic neuroendocrine neoplasms in Krakow and Krakow district in 2007-2011. Endokrynol Pol 2017 0.75
53 [The impact of polychlorinated biphenyls on placental and ovarian steroidogenesis]. Przegl Lek 2011 0.75
54 [Symptoms and early diagnostic possibilities of pancreatic endocrine cells hyperplasia (nesidioblastosis)]. Przegl Lek 2012 0.75
55 [The impact of polichlorinated biphenyls on neoplastic processes]. Przegl Lek 2010 0.75
56 [Diagnostic difficulties in recognizing of pheochromocytoma]. Przegl Lek 2010 0.75
57 [Serum levels of 25(OH)D3 in patients with prostate cancer compared to healthy men]. Przegl Lek 2013 0.75
58 [Assessement of the usefulness of whole body scintigraphy after administration of 6 MBq of 131I in the diagnostic of breast cancer]. Przegl Lek 2011 0.75
59 Graves' ophthalmopathy in patients treated with radioiodine 131-I. Endokrynol Pol 2011 0.75
60 [Influence of estradiol administration mode on plasma insulin-like growth factor-I (IGF-I) and its binding proteins 1 and 3 concentration in postmenopausal women treated with norethisterone acetate]. Ginekol Pol 2011 0.75
61 Case report of a patient with initially inoperable well-differentiated midgut neuroendocrine tumor (WDNT)--PRRT and long-acting somatostatin analogs as the neoadjuvant therapy. Nucl Med Rev Cent East Eur 2012 0.75
62 [Introduction to human genome sequencing in diagnostics]. Przegl Lek 2013 0.75
63 [Iodine-deficiency prophylaxis and the restriction of salt consumption--a 21st century challenge]. Endokrynol Pol 2010 0.75
64 Intake of iodine-containing multivitamin preparations by pregnant women from the Krakow region of Poland. Endokrynol Pol 2011 0.75
65 [Hematological toxicity of radioimmunotherpy with 90Y Ibritumomab]. Przegl Lek 2012 0.75
66 (99m)TC-octreotide scintigraphy and somatostatin receptor subtype expression in juvenile nasopharyngeal angiofibromas. Head Neck 2011 0.75
67 [Evaluation of regional cerebral blood flow using 99mTc-ECD SPECT in ethanol dependent patients: pilot study]. Przegl Lek 2007 0.75
68 [Acute suicidal carbofuran poisoning--case report]. Przegl Lek 2007 0.75
69 NEN - the role of somatostatin receptor scintigraphy in clinical setting. Nucl Med Rev Cent East Eur 2016 0.75
70 Pancreatic neuroendocrine neoplasms - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol 2013 0.75
71 Pituitary insufficiency following traumatic thoracic injury in an adolescent male patient: A case report and literature review. Medicine (Baltimore) 2017 0.75
72 [Alcohol consumption and the risk of insulin resistance--population based study]. Przegl Lek 2007 0.75
73 How far are we from understanding the genetic basis of Hashimoto's thyroiditis? Int Rev Immunol 2013 0.75
74 [Evaluation of the efficacy of Octreotide LAR in the treatment of acromegaly--a yearly observation]. Przegl Lek 2009 0.75
75 Topoisomerase IIα as a prognostic factor in pituitary tumors. Pol Arch Med Wewn 2014 0.75
76 Pancreatic neuroendocrine neoplasms - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol 2017 0.75
77 The somatotropic axis in postmenopausal women during six month of transdermal continuous 17beta-estradiol administration combined with oral medroxyprogesterone. Ginekol Pol 2011 0.75
78 [Quantitative analysis of heart scintigraphy (99mTc-MIBI GSPECT) with regional myocardial wall motion and systolic thickening of left ventricle assessment for detecting myocardial damage in ethanol withdrawal patients]. Przegl Lek 2010 0.75
79 [Retrospective hormonal analysis of incidentally discovered and operated adrenal tumors for subclinical Cushing's syndrome]. Przegl Lek 2010 0.75
80 Optimization of image reconstruction method for SPECT studies performed using [⁹⁹mTc-EDDA/HYNIC] octreotate in patients with neuroendocrine tumors. Nucl Med Rev Cent East Eur 2013 0.75
81 Radioiodine ablation of thyroid remnants in patients with differentiated thyroid carcinoma (DTC) following administration of rhTSH - a comparison with L-thyroxine withdrawal. Endokrynol Pol 2010 0.75
82 [Current opinions on pathogenesis, diagnostic procedures and management of gastric neuroendocrine tumors]. Przegl Lek 2009 0.75
83 [Gastrointestinal tract polyps in acromegaly patients]. Przegl Lek 2010 0.75
84 Colorectal neuroendocrine neoplasms - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol 2017 0.75
85 Radioimmunotherapy in follicular lymphomas, a retrospective analysis of the Polish Lymphoma Research Group's (PLRG) experience. Nucl Med Rev Cent East Eur 2007 0.75
86 [Evaluation of radioiodine 131I treatment in Graves' disease patients with mild orbitopathy]. Przegl Lek 2009 0.75
87 [Influence of selected endogenous and environmental factors on the course and complications of Grave's disease]. Przegl Lek 2014 0.75
88 A case of acromegaly and disseminated follicular thyroid carcinoma. Endokrynol Pol 2010 0.75
89 [Pancreatic endocrine tumors - management guidelines (recommended by the Polish Network of Neuroendocrine Tumors)]. Endokrynol Pol 2008 0.75
90 Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours). Endokrynol Pol 2017 0.75
91 Age, place of living and education influences the pregnancy universal thyroid function screening program attendance - questionnaire study. Endokrynol Pol 2011 0.75
92 Graves' disease with an autonomously functioning thyroid nodule: case report. Pol Arch Med Wewn 2009 0.75
93 Noninsulinoma pancreatogenous hypoglycaemia in adults--a spotlight on its genetics. Endokrynol Pol 2015 0.75
94 [Fusion SPECT/CT in clinical practice]. Przegl Lek 2010 0.75
95 Radioimmunotherapy for lymphoma - analysis of clinical trials and treatment algorithms. Nucl Med Rev Cent East Eur 2007 0.75